Home›Screener›NUVB›Profile
B
69/100

Nuvation Bio

NUVBOncology
← Signals View
📋
Analyst Summary
✓ VERIFIED2026-04-11

Nuvation Bio (NUVB) is the lead sponsor of 6 active clinical trials listed on ClinicalTrials.gov[4], including 3 Phase 3[1], 3 Phase 2[2], 1 Phase 1[3].

Trial NCT05303519[5] evaluates safusidenib in Glioma with a target enrollment of 365 participants. Trial NCT07154706[6] evaluates Taletrectinib in Non-small Cell Lung Cancer (NSCLC) with a target enrollment of 180 participants. Trial NCT06564324[7] evaluates Taletrectinib in Non Small Cell Lung Cancer with a target enrollment of 138 participants.

NUVB has 1 Form 4 insider filing recorded at the SEC in the past 30 days[8].

Sources

  1. ClinicalTrials.gov (2026-04-11) ↗
  2. ClinicalTrials.gov (2026-04-11) ↗
  3. ClinicalTrials.gov (2026-04-11) ↗
  4. ClinicalTrials.gov (2026-04-11) ↗
  5. ClinicalTrials.gov · NCT05303519 (2026-03-05) ↗
  6. ClinicalTrials.gov · NCT07154706 (2026-04-08) ↗
  7. ClinicalTrials.gov · NCT06564324 (2025-11-21) ↗
  8. SEC EDGAR · 0001811063 (2026-04-11) ↗
🔬
Clinical Trials
6
NCT04395677Non Small Cell Lung Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT04919811Non Small Cell Lung Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05303519Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma, Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4, Astrocytoma, IDH-Mutant, Grade 2, Oligodendroglioma, Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06334432Advanced Solid Tumor, HER2-negative Breast Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC), Pancreatic Cancer, Platinum-resistant Ovarian Cancer (PROC)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06564324Non Small Cell Lung Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07154706Non-small Cell Lung Cancer (NSCLC)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
👤
Insider Activity
1
1 filing
Source ↗
sec_edgar · Retrieved 2026-04-11
Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.
Score Breakdown
Score Trend
2026-04-132026-06-02
Signal Summary
PDUFA Dates0
Insider Filings1
Clinical Trials4
Sector Peers (Oncology)
LBPHLongboard Pharmaceuticals
B
SNDXSyndax Pharmaceuticals
C
KURAKura Oncology, Inc.
C
INCYIncyte Corporation
C
HOOKHOOKIPA Pharma
C
Data Provenance
cik1 verified
clinical trial6 verified
insider buy1 verified
trial count4 verified
Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR